Targeting of nanoparticles: folate receptor

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Nanoparticulate medicines enable high-dose, unmodified drug delivery.
• Large, hydrophilic nanoparticles face challenges in cancer cell uptake.
• Targeting ligands can improve tumor specificity and cell penetration via receptor-mediated endocytosis.

Purpose of the Study:

• To review methods for delivering nanoparticles into cancer cells using folate receptor-mediated endocytosis.
• To highlight the advantages of folate-targeted liposomes for cancer therapy.

Main Methods:

• Summarizing various strategies for nanoparticle delivery into cancer cells.
• Focusing on folate receptor-mediated endocytosis pathways.
• Investigating the use of folate-targeted liposomes.

Main Results:

• Folate receptor-mediated endocytosis facilitates nanoparticle entry into cancer cells.
• Overexpression of folate receptors on cancer cells enhances uptake.
• Rapid internalization of folate receptors promotes efficient drug delivery.

Conclusions:

• Folate receptor-mediated endocytosis is an effective strategy for nanoparticle delivery in cancer treatment.
• Folate-targeted nanoparticles, particularly liposomes, show potential for improved tumor specificity and efficacy.